Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by André Pèlegrin
Group name EquipeAP
Item Type Journal Article
Title [Treatment of primary disease (breast, non-small cell lung and prostate cancers) with irradiation in case of de novo metastatic cancer]
Creator Latorzeff et al.
Author I. Latorzeff
Author C. Bourgier
Author B. Pinel
Author C. Hennequin
Author G. Jimenez
Author O. Chapet
Author X. Zasadny
Abstract The basis of treatment of primary disease in case of metastatic cancer at diagnosis is based on the knowledge of the natural history of the disease, the biology of the primary tumour and its metastases, advances in modern radiotherapy techniques (modulated intensity, stereotactic radiotherapy) in order to improve the survival of patients with advanced disease. The clinical concept of oligometastatic disease at diagnosis has repositioned the interest of local treatment for primitive disease because these patients have a slower evolutionary profile than metastatic disease extended from the outset. This article reviews the indication of radiotherapy as a local treatment for primary cancer in a de novo metastatic diagnosed disease in the case of breast cancer, non-small cell lung cancer and prostate cancer.
Publication Cancer Radiotherapie: Journal De La Societe Francaise De Radiotherapie Oncologique
Date Sep 06, 2019
Journal Abbr Cancer Radiother
Language fre
DOI 10.1016/j.canrad.2019.08.004
ISSN 1769-6658
Library Catalog PubMed
Extra 00000 PMID: 31501025
Tags Breast, Cancer métastatique, clinic, Clinical trials, clinique hors équipe, Essais cliniques, Lung, Metastatic cancer, nonvisible, Poumon, Primary tumour, Prostate, Radiothérapie, Radiotherapy, SBRT, Sein, Stéréotaxie, Tumeur primitive
Date Added 2019/09/12 - 09:49:41
Date Modified 2019/12/11 - 18:30:54
Notes and Attachments PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés